how to ask your doctor for glp-1 medications are everywhere—but are they right you? In the latest #90SecondsWithLisaKim, Stanford Medicine endocrinologist Sun Kim, MD, MS, and bariatric and minimally invasive surgeon Dan Azagury, MD, FACS, break down 9 Questions to Ask Your

Then, we will discuss the approaches that can increase the endogenous production of GLP-1 through various stimuli

In conclusion, GLP-1 RAs are an intriguing multitarget treatment option for people with NDs, and future research should focus on optimizing treatment for clinical trials, evolved agonists that can penetrate the central nervous system (CNS), and combination therapies.

Injection bruising is common but preventable

More than 100 million American adults live with obesity, and the arrival of GLP-1 receptor agonists like semaglutide and tirzepatide has triggered an unprecedented surge in patient demand

Independent editorial review, not affiliated

Led by graduate student Jordan Miller '25 and Professor David Han, the team studied national poison control center data and identified a sharp rise in semaglutide-related calls following the FDAs 2021 approval of the medication for chronic weight management